India has authorized two vaccines against Covid-19, paving the way for a massive inoculation program to halt the new coronavirus pandemic in the world’s second most populous country.
The Indian drug regulator has issued an emergency authorization for vaccines developed by the University of Oxford and by biopharmaceuticals AstraZeneca, and another developed by Indian company BharatBiotech.
The country’s initial vaccination plan aims to vaccinate 300 million people by August, from health workers to frontline personnel, including the police and those considered most vulnerable due to their age or other illnesses.
The Serum Institute of India, the world’s largest vaccine manufacturing company, has been contracted by AstraZeneca to make one billion doses for developing nations, including India. On Friday, the United Kingdom was the first to approve the vaccine.
The other vaccine known as Covaxin is developed by Bharat Biotech, in collaboration with government agencies.
Read more in portuguese at Jornal de Angola
Este artigo está disponível em: Português